• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干细胞技术在骨骼再生中的进展。

The Progress of Stem Cell Technology for Skeletal Regeneration.

机构信息

Sensory & Motor System Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.

出版信息

Int J Mol Sci. 2021 Jan 30;22(3):1404. doi: 10.3390/ijms22031404.

DOI:10.3390/ijms22031404
PMID:33573345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7866793/
Abstract

Skeletal disorders, such as osteoarthritis and bone fractures, are among the major conditions that can compromise the quality of daily life of elderly individuals. To treat them, regenerative therapies using skeletal cells have been an attractive choice for patients with unmet clinical needs. Currently, there are two major strategies to prepare the cell sources. The first is to use induced pluripotent stem cells (iPSCs) or embryonic stem cells (ESCs), which can recapitulate the skeletal developmental process and differentiate into various skeletal cells. Skeletal tissues are derived from three distinct origins: the neural crest, paraxial mesoderm, and lateral plate mesoderm. Thus, various protocols have been proposed to recapitulate the sequential process of skeletal development. The second strategy is to extract stem cells from skeletal tissues. In addition to mesenchymal stem/stromal cells (MSCs), multiple cell types have been identified as alternative cell sources. These cells have distinct multipotent properties allowing them to differentiate into skeletal cells and various potential applications for skeletal regeneration. In this review, we summarize state-of-the-art research in stem cell differentiation based on the understanding of embryogenic skeletal development and stem cells existing in skeletal tissues. We then discuss the potential applications of these cell types for regenerative medicine.

摘要

骨骼疾病,如骨关节炎和骨折,是影响老年人生活质量的主要疾病之一。为了治疗这些疾病,利用骨骼细胞的再生疗法一直是临床需求未得到满足的患者的一个有吸引力的选择。目前,有两种主要的策略来准备细胞来源。第一种是使用诱导多能干细胞(iPSCs)或胚胎干细胞(ESCs),它们可以重现骨骼发育过程,并分化为各种骨骼细胞。骨骼组织来源于三个不同的起源:神经嵴、轴旁中胚层和侧板中胚层。因此,已经提出了多种方案来重现骨骼发育的顺序过程。第二种策略是从骨骼组织中提取干细胞。除了间充质干细胞(MSCs)外,还鉴定出多种细胞类型作为替代细胞来源。这些细胞具有不同的多能性特征,允许它们分化为骨骼细胞,并具有多种潜在的骨骼再生应用。在这篇综述中,我们总结了基于对胚胎骨骼发育和骨骼组织中存在的干细胞的理解的基于干细胞分化的最新研究。然后,我们讨论了这些细胞类型在再生医学中的潜在应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c68/7866793/c0a99f4c5a47/ijms-22-01404-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c68/7866793/96bcc7935506/ijms-22-01404-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c68/7866793/c0a99f4c5a47/ijms-22-01404-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c68/7866793/96bcc7935506/ijms-22-01404-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c68/7866793/c0a99f4c5a47/ijms-22-01404-g002.jpg

相似文献

1
The Progress of Stem Cell Technology for Skeletal Regeneration.干细胞技术在骨骼再生中的进展。
Int J Mol Sci. 2021 Jan 30;22(3):1404. doi: 10.3390/ijms22031404.
2
Human stem cell research and regenerative medicine--present and future.人类干细胞研究与再生医学——现状与未来。
Br Med Bull. 2011;99:155-68. doi: 10.1093/bmb/ldr027. Epub 2011 Jun 13.
3
Embryonic origin and Hox status determine progenitor cell fate during adult bone regeneration.胚胎起源和Hox状态决定成体骨再生过程中祖细胞的命运。
Development. 2008 Sep;135(17):2845-54. doi: 10.1242/dev.023788. Epub 2008 Jul 24.
4
[Mesenchymal stem cells and regenerative medicine: future perspectives in osteoarthritis].[间充质干细胞与再生医学:骨关节炎的未来展望]
Med Sci (Paris). 2018 Dec;34(12):1092-1099. doi: 10.1051/medsci/2018294. Epub 2019 Jan 9.
5
Understanding paraxial mesoderm development and sclerotome specification for skeletal repair.理解近轴中胚层发育和软骨体规范,以进行骨骼修复。
Exp Mol Med. 2020 Aug;52(8):1166-1177. doi: 10.1038/s12276-020-0482-1. Epub 2020 Aug 13.
6
Neural crest and mesoderm lineage-dependent gene expression in orofacial development.神经嵴和中胚层谱系依赖性基因在口腔面部发育中的表达
Differentiation. 2007 Jun;75(5):463-77. doi: 10.1111/j.1432-0436.2006.00145.x. Epub 2007 Feb 5.
7
Role of mesenchymal stem cells in regenerative medicine: application to bone and cartilage repair.间充质干细胞在再生医学中的作用:在骨与软骨修复中的应用
Expert Opin Biol Ther. 2008 Mar;8(3):255-68. doi: 10.1517/14712598.8.3.255.
8
Developmental principles informing human pluripotent stem cell differentiation to cartilage and bone.指导人类多能干细胞向软骨和骨分化的发育原则。
Semin Cell Dev Biol. 2022 Jul;127:17-36. doi: 10.1016/j.semcdb.2021.11.024. Epub 2021 Dec 20.
9
Role of induced pluripotent stem cells (IPSCS) in bone tissue regeneration in dentistry: a narrative review.诱导多能干细胞(iPSCs)在牙科骨组织再生中的作用:叙述性综述。
J Biol Regul Homeost Agents. 2020 Nov-Dec;34(6 Suppl. 3):1-10.
10
Origin matters: differences in embryonic tissue origin and Wnt signaling determine the osteogenic potential and healing capacity of frontal and parietal calvarial bones.起源很重要:胚胎组织起源和 Wnt 信号的差异决定了额骨和顶骨的成骨潜力和愈合能力。
J Bone Miner Res. 2010 Jul;25(7):1680-94. doi: 10.1359/jbmr.091116.

引用本文的文献

1
Addressing osteoblast senescence: Molecular pathways and the frontier of anti-ageing treatments.应对成骨细胞衰老:分子途径与抗衰老治疗前沿
Clin Transl Med. 2025 Jul;15(7):e70417. doi: 10.1002/ctm2.70417.
2
Bone fusion materials: past, present, and future.骨融合材料:过去、现在与未来。
Asian Spine J. 2025 Feb 4. doi: 10.31616/asj.2024.0520.
3
Post-Transcriptional Regulatory Crosstalk between MicroRNAs and Canonical TGF-β/BMP Signalling Cascades on Osteoblast Lineage: A Comprehensive Review.miRNAs 和经典 TGF-β/BMP 信号通路在成骨细胞系中的转录后调控串扰:全面综述。

本文引用的文献

1
Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study.iPSC 来源间充质基质细胞在急性激素耐药移植物抗宿主病中的生产、安全性和疗效:I 期、多中心、开放标签、剂量递增研究。
Nat Med. 2020 Nov;26(11):1720-1725. doi: 10.1038/s41591-020-1050-x. Epub 2020 Sep 14.
2
Articular cartilage regeneration by activated skeletal stem cells.激活的骨骼干细胞实现关节软骨再生。
Nat Med. 2020 Oct;26(10):1583-1592. doi: 10.1038/s41591-020-1013-2. Epub 2020 Aug 17.
3
Understanding paraxial mesoderm development and sclerotome specification for skeletal repair.
Int J Mol Sci. 2023 Mar 29;24(7):6423. doi: 10.3390/ijms24076423.
4
How the mechanical microenvironment of stem cell growth affects their differentiation: a review.干细胞生长的机械微环境如何影响其分化:综述。
Stem Cell Res Ther. 2022 Aug 13;13(1):415. doi: 10.1186/s13287-022-03070-0.
理解近轴中胚层发育和软骨体规范,以进行骨骼修复。
Exp Mol Med. 2020 Aug;52(8):1166-1177. doi: 10.1038/s12276-020-0482-1. Epub 2020 Aug 13.
4
Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers.间充质基质细胞治疗移植物抗宿主病:基于机制的生物标志物。
Front Immunol. 2020 Jun 25;11:1338. doi: 10.3389/fimmu.2020.01338. eCollection 2020.
5
Lineage-specific differentiation of osteogenic progenitors from pluripotent stem cells reveals the FGF1-RUNX2 association in neural crest-derived osteoprogenitors.多能干细胞来源的成骨祖细胞的谱系特异性分化揭示了神经嵴来源的成骨祖细胞中FGF1与RUNX2的关联。
Stem Cells. 2020 Sep;38(9):1107-1123. doi: 10.1002/stem.3206. Epub 2020 Jun 9.
6
Cardiac Neural Crest Cells: Their Rhombomeric Specification, Migration, and Association with Heart and Great Vessel Anomalies.心脏神经嵴细胞:它们的神经节段特异性、迁移以及与心脏和大血管异常的关联。
Cell Mol Neurobiol. 2021 Apr;41(3):403-429. doi: 10.1007/s10571-020-00863-w. Epub 2020 May 13.
7
Generation of craniofacial myogenic progenitor cells from human induced pluripotent stem cells for skeletal muscle tissue regeneration.从人诱导多能干细胞生成颅面肌源性祖细胞用于骨骼肌组织再生。
Biomaterials. 2020 Jul;248:119995. doi: 10.1016/j.biomaterials.2020.119995. Epub 2020 Apr 2.
8
Recapitulating the human segmentation clock with pluripotent stem cells.用多能干细胞重现人类胚胎分割时钟。
Nature. 2020 Apr;580(7801):124-129. doi: 10.1038/s41586-020-2144-9. Epub 2020 Apr 1.
9
Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease-a meta-analysis.间充质基质细胞预防和治疗移植物抗宿主病的Meta 分析。
Stem Cell Res Ther. 2020 Feb 18;11(1):64. doi: 10.1186/s13287-020-01592-z.
10
Stepwise strategy for generating osteoblasts from human pluripotent stem cells under fully defined xeno-free conditions with small-molecule inducers.在完全确定的无动物源条件下,使用小分子诱导剂从人多能干细胞生成成骨细胞的逐步策略。
Regen Ther. 2020 Jan 14;14:19-31. doi: 10.1016/j.reth.2019.12.010. eCollection 2020 Jun.